findmyKOL
Clinical trialNCT05123131Active, not recruitingPhase 2Interventional

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

SponsorCancer Trials IrelandEnrollment54Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study aims to evaluate the stringent Complete Response (sCR) rate by the end of two cycles of induction treatment, defined as the proportion of patients who have achieved sCR, according to International Myeloma Working Group (IMWG) criteria, by the end of two cycles of induction treatment.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Aarhus University Hospital

    Aarhus, Denmark

Ireland
  • Beaumont Hospital

    Dublin, Ireland

  • Mater Misericordiae University Hospital

    Dublin, Ireland

  • St James'S Hospital

    Dublin, Ireland

  • University Hospital Waterford

    Waterford, Ireland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2022
Primary completion
24 Jun 2025
Completion
15 Dec 2027
Last update posted
8 Jul 2025
Registered enrollment
54
Registry id
NCT05123131

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.